REVELATION BIOSCIENCES, INC.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 10, 2023 8-K
DEF 14A Dec 30, 2022 DEFINITIVE PROXY STATEMENTS
8-K Dec 21, 2022 8-K
PRE 14A Dec 20, 2022 PRELIMINARY PROXY STATEMENT
8-K Dec 12, 2022 8-K
S-1 Nov 29, 2022 REGISTRATION STATEMENT
8-K Nov 25, 2022 CURRENT REPORT
EFFECT Nov 18, 2022
CORRESP Nov 17, 2022
CORRESP Nov 16, 2022
S-1/A Nov 16, 2022 AMENDMENT NO. 1 TO FORM S-1
UPLOAD Nov 14, 2022
8-K Nov 10, 2022 8-K
10-Q Nov 10, 2022 10-Q
S-1 Oct 31, 2022 REGISTRATION STATEMENT
8-K Oct 25, 2022 8-K
8-K Oct 6, 2022 8-K
SC 13G/A Aug 17, 2022 AMENDMENT TO FORM SC 13G
8-K Aug 17, 2022 8-K
10-Q Aug 15, 2022 10-Q
8-K Aug 1, 2022 8-K
424B3 Jul 27, 2022 PROSPECTUS
EFFECT Jul 25, 2022
S-1/A Jul 25, 2022 AMENDMENT NO. 3 TO FORM S-1
CORRESP Jul 25, 2022
← Newer Page 10 of 16 · 387 filings Older →